Clinical Trial Update: Influenza Vaccination in Patients With Scleroderma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating influenza vaccination in patients with systemic sclerosis (scleroderma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Influenza Vaccine in Scleroderma | Phase 4 | Status: UNKNOWN